“flu” Archives

in
Entry Author Date Location
NanoBio Passes First Key Clinical Trial With Nasal Flu Vaccine, Scopes Other Opportunities 09/16/10 Detroit Ann Arbor
Seattle Genetics’ Dark Horse Fails, The Future of Zymo’s Landmark, PATH Nabs Flu Vaccine Contract, & More Seattle-Area Life Sciences 09/16/10 Seattle
PATH Snaps Up $5M Contract to Make Flu Vaccines For Stockpiling, Hot Conditions 09/15/10 Seattle
Former Solvay Pharma Chief Takes Lead Role at Startup Selecta Biosciences 08/16/10 Boston
Immune Design Follows Corixa Playbook, Sees Data, Deals on the Horizon in Year Three 07/27/10 Seattle
Visterra, Previously Parasol, Expands with $6M 07/12/10 Boston
Theraclone Sciences CEO David Fanning Dies Suddenly 06/14/10 Seattle
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News 06/11/10 Seattle
AVI Biopharma Gets $18M Flu Contract 06/07/10 Seattle
FDA OK’s IMDx H1N1 Test 03/24/10 Boston
AVI Biopharma Eagerly Awaits Data on Muscular Dystrophy Drug 02/01/10 Seattle
The Top Five Biotech Innovations of the 2000s 12/15/09 Seattle
Quidel OKs $25M in Share Buybacks 12/08/09 San Diego
Seattle’s Kineta Rakes in Half of $13M Federal Contract to UW For Vaccine Boosters 11/10/09 Seattle
UW Scientists, Backed by Gates Foundation, Enter “Put Up or Shut Up” Phase with Portable Diagnostic 11/03/09 Seattle
Pulmatrix Scores $30M To Block All Sorts of Bugs That Make People Sick in the Lungs 11/02/09 Boston
UK’s Enigma Diagnostics to Establish U.S. Headquarters in San Diego 10/27/09 San Diego
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News 10/08/09 Seattle
Veratect Secures $4.2M Debt 10/06/09 Seattle
Amazon Goes Mobile, Theraclone Inks $18M Deal, Spiration Pulls In $7M, & More Seattle-Area Deals News 10/06/09 Seattle
Seattle’s Theraclone Strikes $18M Deal to Make Flu-Fighting Antibodies with Japanese Company 10/05/09 Seattle
It’s About Health Care, Not Health Insurance 09/28/09 Seattle
Quidel, Pulling Off a Turnaround, Predicts Record Profit on Demand for Flu Tests 09/10/09 San Diego
Finding HIV’s Weak Spot, Scientists at Seattle’s Theraclone and San Diego’s Scripps See Opening for New Vaccine 09/03/09 National
AVI Developing Swine Flu Drugs 06/22/09 Seattle
Sanofi CEO Bets Outside U.S., Gears Up for Flu Pandemic, and Seeks To Learn From Biotech 06/19/09 Seattle
UW Stem Cell Startup is Born, Global Health’s “Davos” Arrives, MDRNA Unloads Debt, & More Seattle-Area Life Sciences News 06/18/09 Seattle
Sanofi-Aventis Donates 100 Million Flu Vaccine Doses to WHO at Seattle Summit 06/17/09 Seattle
IDRI Offers Flu Vaccine Boosters 06/11/09 Seattle
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment 06/09/09 Boston
Page 2 of 3 « previous page · next page »